A Multicenter, Randomized, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease

Grants and Contracts Details

StatusFinished
Effective start/end date10/10/162/12/20

Funding

  • United Therapeutics Corporation: $11,367.00